orka-001

orka-001: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.

Development Pipeline (1)

Clinical Trials (1)

Phase 1, First-in-human, Double-Blind, Placebo-Controlled, Single Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics, of ORKA-001 in Healthy Participants

NCT06698939·Phase 1·ORKA
Completed

Frequently asked questions

Who is developing orka-001?

orka-001 is being developed by Oruka Therapeutics, Inc..

How many clinical trials involve orka-001?

BioSniper tracks 1 clinical trial involving orka-001.

Get deeper analysis on orka-001

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    orka-001 — Drug Pipeline, Trials & FDA Status | BioSniper